JAN 05, 2021 9:51 PM PST

Nanoparticle Technology Improves Therapeutic Delivery to the Brain

WRITTEN BY: Nouran Amin

For a while, researchers have discovered key mechanisms involved in leading to neurodegenerative diseases. However, despite the discovery of these pathways--translation to clinical therapeutic outcomes has been a challenge.

Now, researchers have found a way to address the issue through a nanoparticle platform to facilitate delivery of drugs to the brain.

"It's very difficult to get both small and large molecule therapeutic agents delivered across the BBB," said corresponding author Nitin Joshi, PhD, an associate bioengineer at the Center for Nanomedicine in the Brigham's Department of Anesthesiology, Perioperative and Pain Medicine. "Our solution was to encapsulate therapeutic agents into biocompatible nanoparticles with precisely engineered surface properties that would enable their therapeutically effective transport into the brain, independent of the state of the BBB."

Learn more about nanoparticle technology:

"To be able to deliver agents across the BBB in the absence of inflammation has been somewhat of a holy grail in the field," said co-senior author Jeff Karp, PhD, of the Brigham's Department of Anesthesiology, Perioperative and Pain Medicine. "Our radically simple approach is applicable to many neurological disorders where delivery of therapeutic agents to the brain is desired."

"To be able to deliver agents across the BBB in the absence of inflammation has been somewhat of a holy grail in the field," said co-senior author Jeff Karp, PhD, of the Brigham's Department of Anesthesiology, Perioperative and Pain Medicine. "Our radically simple approach is applicable to many neurological disorders where delivery of therapeutic agents to the brain is desired."

"In addition to demonstrating the utility of this novel platform for drug delivery into the brain, this report establishes for the first time that systematic modulation of surface chemistry and coating density can be leveraged to tune the penetration of nanoparticles across biological barriers with tight junction," said first author Wen Li, PhD, of the Department of Anesthesiology, Perioperative and Pain Medicine.

Learn more about the blood-brain barrier (BBB):

"For clinical translation, we want to look beyond tau to validate that our system is amenable to other targets," Karp said. "We used the TBI model to explore and develop this technology, but essentially anyone studying a neurological disorder might find this work of benefit. We certainly have our work cut out, but I think this provides significant momentum for us to advance toward multiple therapeutic targets and be in the position to move ahead to human testing."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 13, 2022
Technology
Four-Legged Robots Allowed to Run in The Wild Thanks to New Algorithms
OCT 13, 2022
Four-Legged Robots Allowed to Run in The Wild Thanks to New Algorithms
In a recent study that will be presented at the 2022 International Conference on Intelligent Robots and Systems (IROS) i ...
OCT 17, 2022
Cell & Molecular Biology
Some Highly Repetitive Protein Sequences are Shared by Many Species
OCT 17, 2022
Some Highly Repetitive Protein Sequences are Shared by Many Species
Gene sequences are made up of nucleotide bases, which are 'read' by the cell's machinery in triplets; three ...
NOV 03, 2022
Space & Astronomy
Martian Core Identified Through Planetary Scan
NOV 03, 2022
Martian Core Identified Through Planetary Scan
In a recent study published in Nature Astronomy, a pair of researchers from The Australian National University (ANU) hav ...
NOV 16, 2022
Earth & The Environment
New Details About Earth's First Mass Extinction Unveiled by Geobiologists
NOV 16, 2022
New Details About Earth's First Mass Extinction Unveiled by Geobiologists
In a recent study published in the Proceedings of the National Academy of Sciences, a team of researchers led by Virgini ...
NOV 14, 2022
Cancer
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
NOV 14, 2022
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
About 20% of breast cancers exhibit elevated levels of a protein known as HER2.  You may have heard the classifier ...
DEC 06, 2022
Technology
Haiku Poetry Created by Artificial Intelligence
DEC 06, 2022
Haiku Poetry Created by Artificial Intelligence
In a recent study published in Computers in Human Behavior, a team of researchers from Japan compare human-made artifici ...
Loading Comments...